MedTrace Logo

Persistence-Targeted Smoking Cessation

NCT01654107 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2017-08-21

Study results available
· View outcomes & findings →

Summary

The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

Persistence Targeted Smoking Cessation

8-weeks of smoking cessation counseling ("Persistence Targeted Smoking Cessation")

BEHAVIORAL

Clearing The Air

8-weeks counseling + 12-weeks nicotine lozenge based on NCI protocol, Clearing The Air

DRUG

Nicotine lozenge

12-weeks 4mg nicotine lozenge

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Marc L Steinberg, Ph.D. · Rutgers, The State University of New Jersey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654107 on ClinicalTrials.gov